Results

Total Results: 1,027 records

Showing results for "drug".

261. Final Research Plan: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication
     May 27, 2021 - Food and Drug Administration. Menopause: Medicines to Help You. … Abbreviation: FDA=Food and Drug Administration.

262. Final Evidence Summary: Tobacco Use in Children and Adolescents: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/other-supporting-document19468/tobacco-and-nicotine-use-prevention-in-children-and-adolescents-primary-care-interventions
     April 28, 2020 - Trials of interventions for preventing multiple risky behaviors (eg, smoking, alcohol or drug use, sex … Results from the 2018 National Survey on Drug Use and Health. HHS Publication No. … Drug Alcohol Depend . 2014;140:217-220. doi:10.1016/j.drugalcdep.2014.04.007 47.  … US Food and Drug Administration. Published 2017. Accessed June 26, 2019. … US Food and Drug Administration. Published 2019. Accessed April 24, 2019.

263. Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-screening
     August 06, 2015 - frequency) of subclinical HSV-2 viral shedding KQ 6: Treatment-related adverse events (e.g., adverse drug … Abbreviations: FDA = U.S Food and Drug Administration; PCR = polymerase chain reaction.

264. Archived: Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-screening-november-2016
     August 06, 2015 - frequency) of subclinical HSV-2 viral shedding KQ 6: Treatment-related adverse events (e.g., adverse drug … Abbreviations: FDA = U.S Food and Drug Administration; PCR = polymerase chain reaction.

265. Archived: Final Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan34/sexually-transmitted-infections-behavioral-counseling-september-2014
     May 15, 2013 - unintended pregnancy or another behavior associated with risky sexual behavior (e.g., alcohol misuse, drug … Others based on target populations (e.g., decrease in substance abuse/misuse among current drug

266. Archived: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening-september-2014
     September 22, 2014 - Food and Drug Administration for use on urogenital sites, including male and female urine, as well as … Food and Drug Administration 7 . … To maximize adherence, the CDC recommends that drug treatment be dispensed on site. … CDC suggests that clinicians consider expedited partner therapy, which allows for the delivery of a drug … or drug prescription to the partner by the patient, a disease investigation specialist, or a pharmacy

267. Screening for Thyroid Dysfunction: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YxbZ4t8FPud98ahYtdd5ru
     March 17, 2015 - Screening for Thyroid Dysfunction: Clinical Summary of USPSTF Recommendation Screening for Thyroid Dysfunction Clinical Summary of U.S. Preventive Services Task Force Recommendation Population Nonpregnant, asymptomatic adults Recommendation No recommendation. Grade: I statement (insufficient evidence) …

268. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=18
     January 24, 2017 - Care Interventions to Support Breastfeeding 2016-10-25 Final Research Plan: Screening for Drug

269. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=19
     August 04, 2016 - Message Date Posted Public Comment on Draft Research Plan: Primary Care Screening for Drug

270. Fbqmoapkebekmj7Aqmale5 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/fbQmoAPKeBekmJ7aqmALe5
     June 01, 2014 - Evidence shows that several drug therapies and nonpharmacologic interventions have a small effect on … Food and Drug Administration include acetylcholinesterase inhibitors and memantine. … Food and Drug Administration include AChEIs and memantine. … Treatment of mild to moderate dementia with several drug therapies and nonpharmacologic interventions … Food and Drug Administration–approved drugs for dementia.

271. Screening for Depression in Children and Adolescents: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kAg43FLUnTjCU5ZNaaHQtW
     March 01, 2016 - Food and Drug Administration (FDA). … recommendations on mental health topics pertain- ing to children and adolescents, including illicit drug … showed a 71% response rate versus a 35% response rate in the placebo group, which received a placebo drug … Food and Drug Administration. … Food and Drug Administration; 2007.

272. Screening for Syphilis Infection in Pregnant Women: Evidence for the Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gWJU-ZynehGyLBVYtDmMow
     May 01, 2009 - Procedural Terminology code; or procedural code for anaphylactic shock, unspecified adverse effect of drug … received was 0.1 per 10 000 dispensings; resuscitation, 0.2 per 10 000 dispensings; adverse effect of drug … Johannes et al, 2007 (12) Retrospective cohort To conduct a systematic study estimating the drug-specific … Drug Saf. 2007;30:705-13. [PMID: 17696583] 13. Puhó EH, Szunyogh M, Métneki J, Czeizel AE. … Drug treatment during pregnancy and isolated orofacial clefts in Hungary.

273. Our Partners | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/our-partners
     May 01, 2022 - Food and Drug Administration (FDA) Partners Focused on Healthcare Utilization, Coverage, and Quality

274. Archived: Dementia in Older Adults: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/dementia-older-adults-screening-1996
     January 01, 1996 - impairment and disability due to acute medical illnesses, depression, wandering, incontinence, adverse drug … course. 26-29 29a Conversely, clinicians may mistakenly attribute the symptoms of depression or drug … improved in older patients, and only 3% resolved completely. 50 The most common correctable causes were drug … benefits of cognitive assessment from other components (e.g., medical evaluation, social evaluation, drug

275. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghTxWfpzXrJRXU8SZECvsk
     August 01, 2022 - Food and Drug Administration (FDA)-approved type-specific HSV serologic tests exist to identify genital … *"[tiab] OR "antiviral drug*"[tiab] OR therapy[tiab] OR "antiviral treatment"[tiab] OR "antiviral agent … controlled trial"[pt] OR "controlled clinical trial"[pt] OR randomized [tiab] OR placebo[tiab] OR "drug … controlled trial"[pt] OR "controlled clinical trial"[pt] OR randomized [tiab] OR placebo[tiab] OR "drug … #10 [mh ^"Antiviral Agents"] OR acyclovir OR "antiviral agents" OR "antiviral agent" OR "antiviral drug

276. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
     February 01, 2023 - Food and Drug Administration (FDA)-approved type-specific HSV serologic tests exist to identify genital … *"[tiab] OR "antiviral drug*"[tiab] OR therapy[tiab] OR "antiviral treatment"[tiab] OR "antiviral agent … controlled trial"[pt] OR "controlled clinical trial"[pt] OR randomized [tiab] OR placebo[tiab] OR "drug … controlled trial"[pt] OR "controlled clinical trial"[pt] OR randomized [tiab] OR placebo[tiab] OR "drug … #10 [mh ^"Antiviral Agents"] OR acyclovir OR "antiviral agents" OR "antiviral agent" OR "antiviral drug

277. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
     October 01, 2016 - What are the benefits of dyslipidemia treatment (such as drug or lifestyle interventions) in adults aged … What are the harms of drug treatment of asymp- tomatic dyslipidemia in adults aged 21 to 39 years? … contextual questions (not reviewed sys- tematically): 1 on how intermediate outcomes are af- fected by drug … Regarding treatment, both drug therapy and lifestyle interventions (such as exercise and diet changes … As detailed in the full report, we also found no evidence regarding the effects of drug treatment of

278. Current Processes: Refining Evidence-based Recommendation Development - Table 1 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/current-processes-refining-evidence-based-recommendation-development-table-1
     June 01, 2007 - Food and Drug Administration, Indian Health Service, National Institutes of Health, and Veterans Administration

279. Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWppPe7wLrdrHnbqM2BQu
     December 05, 2017 - Several different formulations of menopausal hormone therapy are approved by the US Food and Drug Administration

280. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=25
     May 27, 2014 - -18 Final Recommendation Statement: Primary Care Behavioral Interventions to Reduce Illicit Drug